Remdesivir for COVID-19: Why Not Dose Higher?

COVID-19에 대한 렘데시비르: 왜 더 높은 용량을 사용하지 않습니까?

Published on 2021-03-182022-09-11
Journal: Antimicrobial Agents and Chemotherapy

[키워드] Abstract COVID-19 drug metabolism GS-441524 metabolism prodrug Remdesivir

[저자] Victoria C Yan, Florian L Muller

[Category] SARS, 치료제,

PMC URL [DOI] 10.1128/AAC.02713-20

[Article Type] Comment

[Source] PMC

No abstract available
Keywords: COVID-19; GS-441524; drug metabolism; prodrug; remdesivir.

All Keywords
【저자키워드】 COVID-19, Remdesivir, GS-441524, drug metabolism, prodrug, 【초록키워드】 Remdesivir, metabolism, GS-441524, prodrug, Abstract,

사용 가능한 초록 없음 {{ 키워드: }} 코로나19; GS-441524; 약물 대사; 전구약물; 렘데시비르.